BIOMAT Database Logo BIOMAT Database Logo

Adjuvant activities in production of reaginic antibody in mice of bacterial cell wall peptidoglycans or peptidoglycan subunits and of synthetic N-acetylmuramyl dipeptides. 1977

H Ohkuni, and Y Norose, and M Hayama, and Y Kinura, and S Kotani, and T Shiba, and S Kusumoto, and K Yologawa, and S Kawata

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D008297 Male Males
D010457 Peptidoglycan A structural polymer of the bacterial cell envelope consisting of sugars and amino acids which is responsible for both shape determination and cellular integrity under osmotic stress in virtually all bacteria. Murein,Pseudomurein
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D005260 Female Females
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

H Ohkuni, and Y Norose, and M Hayama, and Y Kinura, and S Kotani, and T Shiba, and S Kusumoto, and K Yologawa, and S Kawata
Synergistic effect of polyriboinosinic acid:polyribocytidylic acid and either bacterial peptidoglycans or synthetic N-acetylmuramyl peptides on production of adjuvant-induced arthritis in rats.
November 1979, Infection and immunity,
H Ohkuni, and Y Norose, and M Hayama, and Y Kinura, and S Kotani, and T Shiba, and S Kusumoto, and K Yologawa, and S Kawata
Adjuvant activity of synthetic cell-wall peptidoglycan subunits on monoazobenzenearsonate-N-acetyl-L-tyrosine and bacterial alpha-amylase in guinea pigs.
February 1976, Japanese journal of microbiology,
H Ohkuni, and Y Norose, and M Hayama, and Y Kinura, and S Kotani, and T Shiba, and S Kusumoto, and K Yologawa, and S Kawata
[Activation of macrophage by bacterial cell wall peptidoglycans and muramyl dipeptides].
November 1987, Nihon saikingaku zasshi. Japanese journal of bacteriology,
H Ohkuni, and Y Norose, and M Hayama, and Y Kinura, and S Kotani, and T Shiba, and S Kusumoto, and K Yologawa, and S Kawata
Adjuvant activity of monomeric bacterial cell wall peptidoglycans.
February 1974, Biochemical and biophysical research communications,
H Ohkuni, and Y Norose, and M Hayama, and Y Kinura, and S Kotani, and T Shiba, and S Kusumoto, and K Yologawa, and S Kawata
Immunoadjuvant activities of cell walls, their water-soluble fractions and peptidoglycan subunits, prepared from various gram-positive bacteria, and of synthetic n-acetylmuramyl peptides.
July 1975, Zeitschrift fur Immunitatsforschung, experimentelle und klinische Immunologie,
H Ohkuni, and Y Norose, and M Hayama, and Y Kinura, and S Kotani, and T Shiba, and S Kusumoto, and K Yologawa, and S Kawata
Reverse-phase high-pressure liquid chromatography of uridine diphosphate N-acetylmuramyl peptide precursors of bacterial cell wall peptidoglycan.
June 1981, Analytical biochemistry,
H Ohkuni, and Y Norose, and M Hayama, and Y Kinura, and S Kotani, and T Shiba, and S Kusumoto, and K Yologawa, and S Kawata
Adjuvant activity of synthetic N-acetylmuramyl peptides in rats.
January 1977, Infection and immunity,
H Ohkuni, and Y Norose, and M Hayama, and Y Kinura, and S Kotani, and T Shiba, and S Kusumoto, and K Yologawa, and S Kawata
Turnover of bacterial cell wall peptidoglycans.
March 1973, The Journal of biological chemistry,
H Ohkuni, and Y Norose, and M Hayama, and Y Kinura, and S Kotani, and T Shiba, and S Kusumoto, and K Yologawa, and S Kawata
[Biological activities of bacterial cell wall peptidoglycans and their subunits, with special reference to the immunoadjuvant actions (author's transl)].
January 1976, Seikagaku. The Journal of Japanese Biochemical Society,
H Ohkuni, and Y Norose, and M Hayama, and Y Kinura, and S Kotani, and T Shiba, and S Kusumoto, and K Yologawa, and S Kawata
An improved technique for the preparation of Streptomyces peptidases and N-acetylmuramyl-l-alanine amidase active on bacterial wall peptidoglycans.
January 1969, Biochemistry,
Copied contents to your clipboard!